Enliven Therapeutics (ELVN) Q4 2023 Earnings

14MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.57
-0.38
-0.19
0

Details

Expected EPS
-0.536667
Actual EPS
-0.47
Surprise EPS
0.07
Surprise Percent
+12.42%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.47 per share for Q4 2023.

0 Comments

Share your thoughts